Medtronic (NYSE:MDT) plans to spin off its Diabetes segment through an IPO of its subsidiary MiniMed Group, creating a standalone business focused on diabetes care. The company also received FDA ...

Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) ...

The Stealth AXiS system architecture allows support for a variety of surgeon preferences and clinical complexities.

Medtronic (NYSE:MDT) announced today that it received FDA clearance for its Stealth AXiS robotic system for spine surgery.

Medtronic built the Stealth AXiS system to support a wide range of surgeon preferences, clinical complexity, and care settings.

FDA’s clearance of Medtronic’s Stealth Axis surgical system comes on the heels of the company winning a nod for the Hugo ...

Called Stealth AXiS, the surgical system builds on Medtronic’s Mazor robotic platform, as the medical device maker takes ...

On Friday, the U.S. Food and Drug Administration cleared Medtronic plc’s MDT Stealth AXiS surgical system for spine surgery. The Stealth AXiS system is cleared for spine procedures in the United ...

Medtronic earned the FDA’s 510(k) clearance for its Stealth AXiS system that brings planning, navigation and robotics into ...

Medtronic (NYSE:MDT) recently lost a major antitrust lawsuit that resulted in a multi hundred million dollar damages award ...